.
There have been various obstacles to investigating the immediate type of spontaneous hypersensitivity in man. These have included the lack of in vitro methods of measuring allergic antibody and a limitation on the types of investigations that can be done in man without risk. Models of hypersensitivity using immunized animals have not involved antibody of the type occurring in spontaneous allergy in man. The passive transfer of immediate cutaneous reactivity [Prausnitz-Kustner reaction ( 1 ) ] to other human subjects has remained the classical method of investigation of allergic antibody. This technique is limited to the study of cutaneous wheal and erythema reactions and carries with it the risk of transmission of certain viral diseases. By this method, allergic antibody has been characterized as a nonprecipitating, heat labile, skin-sensitizing antibody that persists at the injected site for long periods of time (2) . The nature of the serum fraction containing allergic antibody, believed to be a y1A type of immunoglobulin by several investigators (3) , has been the subject of controversy in regard to either electrophoretic migration or sedimentation characteristics as demonstrated by ultracentrifugal analysis.
The availability of an animal model with the immediate type of spontaneous hypersensitivity as found in dogs with spontaneous pollen hyper-sensitivity has provided a means of investigation of the immunopathology resulting from the interaction of allergic antibody and antigen. With this model, the hypersensitivity has been transferred to normal dogs (4) and the canine allergic antibody characterized and compared with human allergic antibody (5) .
The immediate type of spontaneous hypersensitivity, a common clinical occurrence, is most frequently directed against materials that are mixtures of poorly characterized antigens such as pollen or animal epithelial proteins. The occurrence of immediate wheal and erythema type of hypersensitivity in certain patients to animal proteins that are available in relatively pure form has provided a means of studying single antigen-allergic antibody systems (6, 7) .
It has been reported that allergic antibody (reagin, skin-sensitizing antibody, atopic antibody) from man will sensitize the skin of other primates (8) . This transfer of cutaneous reactivity to a heterologous species has recently been directed toward the investigation of cutaneous reactions of various antigens and their respective skin-sensitizing antibodies in monkeys (9, 10) .
Based on the previous observation of passive cutaneous (2) .
Passive cutaneous reactions. One-tenth ml of various sera was injected intracutaneously. Forty-eight hours later the monkeys received 4 ml of 0.5% Evans blue dye intravenously followed in 15 minutes by intracutaneous injection of 0.05 ml of 0.1% pollen antigens or HSA or HGG containing 50 /Ag N per ml. Sites were examined in 30 minutes, and positive reactions were characterized by edema and cutaneous blueing (Figure 1 ).
Systemic sensitization of monkeys. Monkeys were sensitized by intravenous injection of reaginic sera in divided doses of 25 or 40 ml per kg body weight. The injections were given at daily intervals, and animals were challenged 48 hours after the last injection. Anaphylactic challenge consisted of intravenous injection of 2 ml of 3% ragweed antigen or 2 ml containing 5 mg HSA N preceded by intravenous injection of 4 ml of 0.5%o Evans blue dye. The volume and concentration of ragweed antigen chosen for intravenous anaphylactic challenge were based on the amount of antigen resulting in canine anaphylaxis in dogs passively sensitized with canine antiragweed antiserum. The amount of HSA chosen for challenge was arbitrarily selected as an amount that would presumably be in excess of that required to produce anaphylaxis. That quantities of both antigens were in excess was demonstrated by loss of reactivity to local cutaneous testing in those passively sensitized monkeys surviving anaphylaxis.
Aerosol exposure of animals. After total body sensitization by human allergic serum, unanesthetized monkeys were placed in an Isolator chamber and aerosolized with 3% ragweed delivered by a no. 40 DeVilbiss nebulizer in a manner previously described for similar experiments 1 Pentex Corp., Kankakee, Ill.
using dogs (4 Blood histamine determinations. Blood histamine levels were determined by the method of Shore, Burkhalter, and Cohn (12) . During anaphylactic shock histamine levels were determined on blood samples obtained by cardiac puncture.
Post-mortem examinations were done within 30 minutes of spontaneous death or sacrifice of monkeys.
Results

Local cutaneous reactivity
Examples of cutaneous reactivity transferred by intracutaneous injections of human sera are shown in Figure 1 . Columns A and B demonstrate reactions at transfer sites and the method of titering passive transfer reactions. Column C shows the destruction of reaginic antibody by heating reaginic serum to 56°C for 4 hours before passive transfer experiments. In this monkey even undiluted canine antiragweed serum gave only a weakly positive reaction (column D), but in other experiments the same canine allergic serum was positive to a dilution of 1: 5. Table II) . Thus, approximately a four-to eightfold increase in blood histamine concentration occurred during anaphylaxis. Lee-White clotting times (13) showed no change during the period of anaphylaxis in contrast to the infinite clotting times observed during acute canine passive anaphylaxis (4).
Post-mortem abnormalities in monkeys after anaphylactic shock were observed only in the heart and lungs. Microscopic examination of liver, kidneys, spleen, and large and small intestines of monkeys C and F were done and showed no definite abnormalities. Microscopic examination of lungs from monkeys C, D, F, and G showed acute emphysema. Thus, acute emphysema occurred whether there was an intravenous challenge alone (monkey G), aerosol challenge alone (monkey D), or both (monkeys C and F). Abnormalities were observed in the hearts of all monkeys following anaphylaxis. The microscopic changes observed in these hearts are recorded in Table III . Figure 2 depicts an example of a myocardial lesion with a focal infiltrate of lymphocytes and neutrophiles. Although the pericardial adipose tissue shows some inflammatory reaction, the myocardium constitutes the primary site of the exudative reaction. Arteritis, focal necrosis, and inflammatory cells in the myocardium of monkey D were present although challenged only by aerosol exposure to antigen. However, the concentration of aerosolized ragweed antigen used in these 
Loss of capacity to accept sensitization
One month after the experiment recorded in Table II , monkeys A and B, which had previously been passively sensitized by intravenous injection of 120 or 75 ml of human allergic sera, respectively, were injected with human sera, this time locally with 0.1 ml of sera from Donors 1, 2, and 3 and these sites tested for the presence of immediate type sensitivity to ragweed, HSA, or HGG. Reactions were negative, indicating the loss of ability to accept skin sensitivity as a result of prior injection of human serum. The initial injections of human sera that resulted in passive sensitization of the monkeys had also actively sensitized the monkeys. Thus, after a latent period, the injection of additional human reaginic serum failed to sensitize the monkey skin. Sera collected from monkeys A and B were tested for the presence of precipitating antibody against human serum, human gamma globulin, and human serum albumin by ring precipitin and Ouchterlony type double gel diffusion precipitin reactions (2) . No precipitating antibody was detected by these tests, but the sera of monkeys A and B demonstrated the presence of circulating antibody against human serum protein antigens by sensitization of normal monkey skin for passive cutaneous anaphylactic reactions against human serum. In addition, monkeys A and B demonstrated symptoms of anaphylaxis accompanied by the generalized cutaneous blueing reaction when challenged intravenously with 2 ml of human serum. This reaction never occurred in monkeys at the time of the first injection of human serum.
Discussion
Methods of studying allergic antibody include the passive transfer of cutaneous reactivity in man and the transfer of cutaneous and total sensitivity in dogs. These models provide a means of comparative study of this antibody. The transfer of local cutaneous and total body sensitivity by human allergic serum to monkeys provides a third major model for the study of allergic antibody.
The events presumed to occur in a passive cutaneous reaction after sensitization with allergic antibody in man include the attachment of allergic antibody to skin cells, reaction of injected antigen with antibody, the release of chemical mediators from cells, and resultant increase in capillary permeability. The latter is demonstrated by the characteristic wheal reaction and made more visible by extravasation of Evans blue dye. The passive cutaneous anaphylactic reaction of Ovary (2) is a similar reaction as a result of induced, skin-fixing animal antibody. The allergic antibody occurring in man will attach to normal human leukocytes in vitro by passive sensitization as detected by histamine release determination (14) .
Canine allergic antibody from dogs with ragweed pollinosis, asthma, and dermatitis will passively transfer cutaneous, bronchial mucosal, and anaphylactic sensitivity (4). Histamine levels and pathologic changes during anaphylaxis in dogs passively sensitized with this canine reaginic serum can thus be compared with induced anaphylaxis in the dog in which the antibody has not yet been defined. This model of the immediate type of hypersensitivity provides a useful comparison between the immediate type of hypersensitivity of two species, man and dog.
Human allergic antibody has the following immunologic characteristics: it is a nonprecipitating antibody, which is heat labile at 56°C, fixes to skin, and persists at the skin site (3). Canine allergic antibody has identical characteristics in completed studies using presently developed immunologic techniques (5) . Although in vitro methods of detecting antibody in human allergic sera have evolved ( 15 ), it has not been established that these in vitro techniques actually measure allergic antibody.
As demonstrated in the experiments described, the injection of sufficient amounts of human allergic serum into monkeys results in total body sensitization. The monkey that has been totally sensitized in this manner can react to antigenic challenge with the specific antigen-human antibody reaction in a manner similar to the sensitive human. The use of the monkey for this type of sensitization is obligatory, since no other nonhuman species has been found to accept the transfer of human allergic antibody. Skin-sensitizing activity of canine antisera will transfer to man and monkey, but human allergic antisera will not transfer to dog, guinea pig, or rabbit.
The availability of the monkey sensitized with human serum provides several potentially useful areas of investigation. The cutaneous reaction has been used as a method of antigen evaluation (9, 10) and study of fractions of allergic antisera (16) . The use of Evans blue dye as an indicator in these reactions provides an indication of wheal and erythema reactivity, making a reaction more visible for graphic recording. The extravasation of Evans blue dye at the site of cutaneous reaction is an indication of the increased capillary permeability as a result of the antigen-antibody reaction and release of mediators. This occurs inI a local mucosal reaction demonstrated in these experiments in which antigen was placed in contact with the conjunctival mucosa. Blueing of the bronchial mucosa occurs in those monkeys with systemic sensitivity after exposure to specific antigen in aerosol form with subsequent development of symptoms of respiratory distress. Finally, during systemic anaphylactic shock in the passively sensitized monkey injected with Evans blue dye before antigenic challenge, a cutaneous blueing reaction is consistently observed. This varies in different animals from a generalized blueing to circumscribed areas of cutaneous blueing with an appearance not dissimilar from that of acute urticarial reactions, as may be seen in anaphylaxis in man. The generalized blueing suggests the occurrence of an increase in cutaneous capillary permeability as the result of the systemic reaction.
The events and mechanisms resulting in anaphylactic shock in the passively sensitized monkey appear to be consistent with the following pathophysiologic pattern. After intravenous injection of human allergic serum, reaginic antibody results in systemic sensitization with fixation of the antibody to cells demonstrated by the general cutaneous and bronchial reactivity to antigen. After intravenous challenge, the antigen-allergic antibody interaction results in histamine release demonstrated by increase in blood histamine levels. The subsequent increase in vascular permeability demonstrated by generalized cutaneous blueing is followed by clinical symptoms of shock. The concomitant occurrence of smooth muscle spasm is shown by symptoms of vomiting, micturition, and diarrhea in varying degree, and the pulmonary symptoms and pathologic demonstration of pulmonary emphysema may represent acute changes resulting from the smooth muscle spasm in the bronchi. The variations in type or severity of symptoms and variation in severity of pathologic changes represent biologic differences between experimental subjects. The occurrence of the pathologic changes of acute emphysema in some of the monkeys examined after anaphylactic shock represents pulmonary abnormalities that may have contributed to the systemic symptoms of anaphylaxis. Since the symptoms of anaphylactic shock do not occur in passively sensitized monkeys challenged by aerosol alone, it appears reasonable to consider the anaphylactic shock primarily the result of the intravenous challenge, with pulmonary manifestations a secondary phenomenon.
The pathologic abnormalities in the monkeys after passive anaphylaxis represent changes resulting from the specific conditions of method of passive sensitization, challenge, duration of anaphylaxis, and whether death occurs spontaneously. The acute emphysema demonstrated in these monkeys after anaphylaxis is an abnormality not unexpected in view of the respiratory symptoms occurring during shock and similar observations in some humans (-17) and some dogs (4) after spontaneous or experimental anaphylaxis. The myocardial abnormalities observed in all sensitized monkeys exposed to the respective antigen are striking in terms of consistency and character. These changes appear to represent primary changes as the result of the antigen-allergic antibody interaction. Similar myocardial changes have not been described in man (17) . Such myocardial abnormalities may represent specific species localization of pathologic changes in the monkey in anaphylaxis [comparable to the liver, gall bladder, and intestinal tract abnormalities in the dog (4, 5)], or similar abnormalities may be found when larger series of post-mortem studies of human anaphylaxis are available. Further investigation of the myocardial abnormalities described in these experiments is in progress. Studies to correlate the myocardial abnormalities with severity and duration of anaphylactic shock are required.
The duration of passively transferred systemic sensitivity will depend on the antibody content of the sensitizing serum, amount of serum given, and the half-life of human reaginic antibody (which has not yet been determined) in the monkey. Finally the duration of the passive sensitivity in the monkey depends on the development of monkey antibody against the sensitizing serum and immune elimination of the sensitizing antibody from the monkey. The present experiments indicate that monkeys receiving amounts of serum used in these studies cannot be used for sensitization after 1 month; two monkeys developed sensitivity to the human sera used for passive immunization.
The antibody developed by the monkeys against human serum was demonstrated only by active anaphylaxis or passive cutaneous anaphylaxis and not by precipitation reactions. Monkeys immunized with human serum in Freund's adjuvant develop precipitating antibodies (18) . The difference between these immunologic responses of monkeys is probably dependent upon the adjuvant administered with the antigenic serum.
Summary
Total antibody sensitization of monkeys occurs with sufficient passively transferred human allergic serum. Cutaneous, respiratory, and anaphylactic reactions can be studied with this model of human hypersensitivity. The symptoms, blood histamine levels, and pathologic changes in the passively sensitized monkey can be compared with a similar type of reaction in the dog. Microscopic pathologic changes occurring in anaphylaxis in monkeys sensitized by human allergic sera were acute pulmonary emphysema and arteritis, focal necrosis, and focal hemorrhages in the myocardium.
